Personal

Place of Birth: Buenos Aires, Argentina

Date of Birth: April 18, 1959.

Citizenship: U.S.A.

Languages: English/Spanish

Higher Education

Medical School

1984University of Buenos Aires, School of Medicine, M.D.
Foreign Medical Graduate Examination in the Medical Sciences.
1988Appl. No. 397-436-7

 

Postgraduate Positions

1985-86Internship, Internal Medicine,
Durand University Hospital,
Buenos Aires, Argentina
1986-87Fellowship, Dermatology,
Muniz Infectious Disease University Hospital
Buenos Aires, Argentina
1987-90Research Associate,
Department of Dermatology
Mount Sinai Medical Center,
Miami Beach, FL 33140
1990-91Internship. General Surgery.
Department of General Surgery.
Mount Sinai Medical Center
Miami Beach, FL 33140
1991-94Fellowship, Dermatology
Department of Dermatology
University of Miami
Miami, FL 33101
1994-01Clinical Instructor
Department of Dermatology
University of Miami
Miami, FL 33101
200I-08Voluntary Assistant Clinical Professor
Department of Dermatology
University of Miami
Miami, FL 33101
2002-07Chief of Dermatology
Mercy Hospital
Miami, FL 33133
2002-presentSenior Medical Attending
Mercy Hospital
Miami, FL 33133

Certification

1992Diplomate of the American Board of Dermatology
Florida Medical License ME 65566
California Medical License C157555
2001-18Fellow, American Society for Mohs Surgery

Experience

1994-presentPrivate Practice

Hospital Affiliations

Mercy Hospital

Clinical Trials

2004-2008Safety and tissue augmentation persistence of Radiesse. Clinical Investigator.
2003Evaluation of Intense Pulse Light Estelux for the treatment of acne. Clinical Investigator.
1997-2001Evaluation of Artecoll, PMMA microspheres in 3.5% collagen for soft tissue augmentation. Clinical Investigator.

Publications

Book Chapters

1.1. Hahn EF, Busso ME, Miami AM, and Resnick L. Nucleotide dimers as anti-HIV agents, in Martin JC, (ed): Nucleotide analogs as antiviral agents. ACS Symposium series, Washington DC, 1989; 401: 156-169.
2.Resnick L., Busso ME, and Duncan RC, Anti-HIV screening technology. Heterosexual transmission of AIDS. Alexander N (ed). Wiley-Liss 1989; 311-327.
3.Busso M. Cosmetic Dermatology Procedure Manual. Leonard AL and Hanke CW (ed). Physicians’ Continuing Education Corp. 2007; 67-72.

Publications in Refereed Journals

1.Hahn EF, Busso ME, Miami AM, and Resnick L. Nucleotide dimers as anti-HIV agents, in Martin JC, (ed): Nucleotide analogs as antiviral agents. ACS Symposium series, Washington DC, 1989; 401: 156-169.
2.Resnick L., Busso ME, and Duncan RC, Anti-HIV screening technology. Heterosexual transmission of AIDS. Alexander N (ed). Wiley-Liss 1989; 311-327.
3.Busso M. Cosmetic Dermatology Procedure Manual. Leonard AL and Hanke CW (ed). Physicians’ Continuing Education Corp. 2007; 67-72.

1.Busso ME, Mian AM, Hahn EF, and Resnick I. Nucleotide dimers suppress HIV expression in vitro. AIDS Res Hum Retroviruses. 1988; 4:449-455.
2.Agarwal RP, Busso ME, Mian AM, and Resnick L. Uptake of 2′, 3′ dideoxyadenosine in HIV infected and non-infected human cells. AIDS Res Hum Retroviruses. 1989; 5:527-536.
3.Davila E, Wallack MK, Resnick L, Busso ME, Gronka S, Darnell E. and Bash JA. Clinical response to IL-2/LAK therapy of advanced melanoma in an HIV positive patient. Cancer Detection and Prevention. 1989; 7:835-839.
5.Busso ME and Resnick L. Anti-HIV effects of dextran sulfate are strain dependent and antagonistic or synergistic when dextran sulfate is given in combination with dideoxynucleosides. Antimicrob Agents Chemother 1990; 34: 19911995.
6.Busso ME, Thornwaite J, and Resnick L. HIV-induced syncytium formation requires the formation of conjugates between virus infected and uninfected T-cells in vitro. AIDS 1991; 5:1425 1432
8.Althaus IW, LeMay RJ, Gonzalez AJ, Deibel MR, Sharma SK, Kezdy FJ, Resnick L, Busso ME, Aristoff PA, and Reusser F. Enzymatic kinetics studies with the non­ nucleoside HIV RT inhibitor U-9843. Experience 1992; 48: 1127-1132.
9.Romero DL, Morge RA, Genin MJ, Biles C, Busso ME, Resnick L, Althaus IW, Reassure F, Thomas RC, and Tarpley WG. BHAP reverse transcriptase inhibitors: Structure activity relationships of novel substituted indole analogues and the indentification of a second generation chemical candidates. (J. Med Chem. 1993;36:1505-1508.
11.Resnick L., Busso ME, and Duncan RC, Anti-HIV screening technology. Heterosexual transmission of AIDS. Alexander N (ed). Wiley-Liss 1989; 311-327.
12.Busso ME and Resnick L. Development of an assay that detects transcriptionally component Human Immunodeficiency Virus type one particles. J of Virol Methods 1994, 47: 129-140.
14.Nouri K, Busso ME, Machler BC. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C. Cutis. 1997;60:289-290.
15.Elgart GW, Hanly A, Busso ME, Spencer JM. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy. J Am Acad Dermatol 1999 Feb; 40(2 Pt 2):315- 317.
17.Cohen SR, Bemer CF, Busso M, Gleason MC, Hamilton D, Holmes RE, Romano JJ, Rullan PP, Thaler MP, Ubogy Z, Vecchione TR. ArteFill: a long-lasting injectable wrinkle filler material— Summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):64S-76S
18.Busso M and Karlsberg P. Cheek augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse).Cosmet Dermatol 2006.Sep;19(9):583-588.
20.Graivier M,. Bass LS, Busso M, Jasin M, Narins R,Tzikas T. “Calcium Hydroxy/apatite (RADIESSE) for Correction of the Mid- and Lower Face: Consensus Recommendations”Journal of Plastic and Reconstructive Surgery -up.
21.Smith S, Busso M, McClaren M, Bass LS. A randomized. bilateral, prospective comparison of calcium hydroxylapa tite microspheres \./ versus human-based collagen for the correction of nasolabial folds.Dermatol Surg. 2007 Dec;33 Suppl 2:S112-21; discussion S121
23.Graivier MH , Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium h drox la atite Radiesse for correction of the mid- and lower face: consensus recommendations Plast Reconstr Surg. 2007 Nov;120(6 Suppl):55S-66S.
24.Busso M, Voigts R. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine Dermatol Surg. 2008 Jun;34 Suppl 1:S16-23; discussion S24.
25.Nouri K, Busso ME, Machler BC. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C. Cutis. 1997;60:289-290.
26.Marmur E, Green L, Busso M. Controlled, randomized study of pain levels in subjec ts treated with calcium hydroxvlapatite, premixed with lidocaine for correction of nasolabial folds. Dermato l Surg. 2010 Mar;36(3):309-15. doi: 10.1111/j.1524-4725.2009.01435
28.Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010 Mar;30(2):235-88.
29.Busso M. Additional commentary on “addition of lidocaine to fillers”. Dermatol Surg. 2010 Nov;36(11): 1795-6.
31.Redbord KP, Busso M, Hanke CW. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther. 2011 Jan-Feb;24(1):71-81. Doi:10.1111/j. 1529-8019.2010
32.Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R,et al. Facial Soft-Tissue Fillers: Assessing the State of the Science conference-Proceedings report. J Am Acad Dermatol. 2011 Apr;64(4 Suppl):S53-65.
34.Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, et al. Facial soft-tissue fillers conference: assessing the state of the science. Plast Reconstr Surg. 2011 Apr;127(4 Suppl):22S-S. Erratum in: Piast Reconstr Surg. 2011 May;127(5):2138-9
35.Hanke CW, Moy RL, Roenigk RK, Roenigk HH Jr, Spencer JM, Tierney EP, Bartus CL, Bernstein RM, Brown MD, Busso M, Carruthers A, Carruthers J, lbrahimi OA, Kauvar AN, Kent KM, Krueger N, Landau M, Leonard AL, Mandy SH, Rohrer TE, Sadick NS, Wiest LG. Current status of surgery in dermatology. J Am Acad Dermatol. 2013 Dec;69(6):972-1001.
36.Busso M, Applebaum D, Tzickas T et al. Hyaluronic acid fillers: the science. Prime 2014;2(2):42-48
38.Jacob, B. Kinney, M. Busso, et al High Intensity Focused Electro-Magnetic Technology (HIFEM) for Non-Invasive Buttocks A Lifting and Toning of Gluteal Muscles: A Multi-Center Efficacy and Safety Study. Journal of Drugs in Dermatology. 2018 Nov (17) in print
39.Busso M, Denkova R (2019) High-Intensity Focused Electromagnetic (HIFEM) Field Therapy Used for Non-Invasive Buttock Augmentation and Lifting: Feasibility Study. J Aesthet Reconstr Surg. Vol 5 No.1:2.

 

Teaching Awards Received

1994George Laonnides Teaching Award. Department of Dermatology, University of Miami. Miami, Florida.
2001-2008Voluntary Assistant Clinical Professor
Department of Dermatology
University of Miami
Miami, FL 33101
1994-2001Clinical Instructor
Department of Dermatology
University of Miami
Miami, FL 33101

Professional

1991-presentProfessional and Honorary Organizations
1994-presentAmerican Academy of Dermatology, Fellow.
2001-20018Florida Society of Dermatology.
1984-1994American Society for Mohs Surgery, Fellow

 


Honors and Awards

1984-1994Honoris Diploma (maximum academic honor) University of Buenos Aires, School of Medicine. Buenos Aires, Argentina.
Upjohn Research Award. Department of Dermatology, University of Miami. Miami, Florida.
1995George Laonnides Teaching Award. Department of Dermatology, University of Miami. Miami, Florida.